MDT - Company ID 0001613103
The table below shows Medtronic plc's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | $1.09B | $986.00M | $875.00M | $1.08B | $1.29B | $278.00M |
| Capital expenditure | $504.00M | $520.00M | $354.00M | $426.00M | $378.00M | $334.00M |
| Investing cash flow | -$719.00M | -$259.00M | -$539.00M | -$1.58B | -$784.00M | $8.00M |
| Dividends paid | $910.00M | $898.00M | $918.00M | $903.00M |
Medtronic plc reported operating cash flow of $7.04B for fiscal year 2025. That is up 3.8% from $6.79B in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $5.22B (FY 2016) to $7.04B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $846.00M |
| $778.00M |
| Stock buybacks | $123.00M | $2.49B | $152.00M | $336.00M | $315.00M | $0.00 |
| Financing cash flow | -$1.38B | -$731.00M | -$501.00M | -$950.00M | -$1.05B | $1.96B |